Print

ENGAGE: Surveys to Assess Decision-Making on Genetic Counseling and Testing for Lynch Syndrome

https://www.facingourrisk.org/research-clinical-trials/study/416 /engage-surveys-to-assess-decision-making-on-genetic-counseling-and-testing-for-lynch-syndrome

Clinicaltrials.gov identifier:
NCT07106359 (https://clinicaltrials.gov/show/NCT07106359)

Surveys, Registries, Interviews
Clinical trial for untested individuals at risk for Lynch syndrome

Study Contact Information:

Please contact the study coordinator, Kaylee Burgan, at [email protected] or [email protected]


About the Study

We are conducting a clinical trial to see if our education materials help people at risk for Lynch syndrome decide about seeking genetic services, such as genetic counseling and testing. We are first recruiting individuals who have been tested for Lynch syndrome to help us identify their untested relatives to participate in the clinical trial. Untested relatives will be randomized into one of two groups and will complete 3 online surveys over 6 months.

What the Study Involves

This is a randomized clinical trial to see if our education materials help people at risk for Lynch syndrome decide about seeking out genetic services. Trial participants will be randomized into one of two groups: one group will receive an information letter, and the other group will receive an information letter and a booklet.

We need tested individuals to help us identify their eligible relatives to participate in the trial.

Tested individuals will:

Untested relatives will:

Click here to get started.

Lead Researcher

Haoyang Yan, PhD
University of Alabama at Birmingham (UAB), Department of Family and Community Medicine
[email protected]


This Study is Open To:

Eligibility:

Tested individuals must be:

Untested relatives must be:

This Study is Not Open To:

Exclusions:

Tested individuals:

Untested relatives must be:


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.